How Old is Too Old for CAR-T Cell Therapies in Multiple Myeloma?
Transplant Cell Ther
.
2023 Jun;29(6):343-344.
doi: 10.1016/j.jtct.2023.05.001.
Authors
Sridevi Rajeeve
1
,
Saad Z Usmani
2
Affiliations
1
Hematology & Oncology Fellowship, Icahn School of Medicine at Mount Sinai, New York, NY.
2
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
PMID:
37263725
DOI:
10.1016/j.jtct.2023.05.001
No abstract available
MeSH terms
Aged
Humans
Immunotherapy, Adoptive
Multiple Myeloma* / therapy
Receptors, Chimeric Antigen* / genetics
T-Lymphocytes
Substances
Receptors, Chimeric Antigen